GALACTOSYLCERAMIDE, GLUCOSYLCERAMIDE, LACTOSYLCERAMIDE, AND SPECIFIC CATCHERS THEREFOR FOR USE IN THE PROPHYLAXIS OR THERAPY OF PREDIABETES, DIABETES AND/OR ASSOCIATED COMPLICATIONS

摘要

The use of glycolipids, in particular galactosylceramide, glucosylceramide andlactosylceramide, and specific catchers therefor (antibodies or lectins), inparticular monoclonal antibodies, for use in the prophylaxis or therapy ofprediabetes, diabetes and/or associated complications in an individual and foruse in the production of pharmaceutical preparations for treatment of saidconditions is disclosed.